Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
CARsgen Therapeutics Holdings Limited Stock Code HK CARsgen Therapeutics a company focused on innovative CAR Tcell therapies for the treatment of hematologic malignancies and solid tumors announces reaching agreements with an investment fund managed...
HBM Alpha Therapeutics HBMAT Inc an innovative biotechnology company incubated by Harbour BioMed HKEX announced a strategic collaboration and license agreement with a business partner to advance novel therapies targeting corticotropinreleasing hormo...
Samsung Bioepis Co Ltd today announced that PYZCHIVA ustekinumabttwe a biosimilar to Stelara ustekinumab is now available in the United States PYZCHIVA has been approved for the treatment of moderate to severe plaque psoriasis
LabConnect and Australian Clinical Labs ACL Specialised Trials have forged a strategic partnership to expand support of clinical trials in Australia and the AsiaPacific region
As global capital reassesses the investment value of innovative Chinese companies the development of innovative vaccines in China is in full swing On February PRC vaccine leader AIM Vaccine HK announced that its selfdeveloped mRNA shingles vaccine h...
SK Biosciences development of vaccine for Japanese encephalitis could not only help to protect against Japanese Encephalitis but also pave the way to the development of an mRNA technology that could be potentially adapted in a matter of weeks to deve...
The future of biopharmaceutical innovation will take center stage at BIOPLUSINTERPHEX KOREA BIX returning on October at Coex Seoul To explore the most recent developments influencing the future of healthcare BIX will bring together experts innova...
Sandoz the global leader in generic and biosimilar medicines announces the launch of Pyzchiva ustekinumabttwe in the US From today the medicine is commercially available to patients across the US
Celltrion today announced that the European Commission EC has granted marketing authorization for Avtozma CTP a biosimilar referencing RoActemra tocilizumab Avtozma has been approved for all indications of its reference product including moderate to...
Roche unveiled today its proprietary breakthrough sequencing by expansion SBX technology establishing a new category of nextgeneration sequencing SBX chemistry combined with an innovative sensor module offers ultrarapid highthroughput sequencing that...
